News

Marcus Samuelsson: From TB to Top Chef


1 Jul 2012
by Working Group

This post originally appeared on NPR – click here to listen to the interview and read the full story

Marcus Samuelsson owns two restaurants in New York City and two restaurants in Sweden. He’s cooked for President Obama and prime ministers, served as a judge on Top Chef andChopped, and recently competed against 21 other chefs on Top Chef Masters. (He won.) He’s the youngest chef ever to receive two three-star ratings from The New York Times.

Samuelsson’s journey to some of the most celebrated restaurants in the U.S. was a long one — and started several thousand miles away. He was born in rural Ethiopia, where he contracted tuberculosis when he was 3 years old. His mother, who was also battling the disease, walked with Samuelsson and his sister 75 miles to a hospital in Addis Ababa. Though Samuelsson and his sister recovered, their mother did not. After her death, both Samuelsson children were adopted by a family in Sweden.

Samuelsson details his path from Sweden, where he learned to cook from his grandmother Helga, to New York City and the Food Network in his memoir, Yes, Chef — in which he pays homage to his Swedish family and to food.

More News
14 Aug 2019
FDA released the following press release on Wednesday, August 14th: The U.S. Food and Drug Administration today approved Pretomanid Tablets in combination with bedaquiline and linezolid for the treatment of a specific type of highly treatment-resistant tuberculosis (TB) of the lungs. “The threat of...
27 Jun 2019
-- Globe Newswire reported on June 20th -- Spero Therapeutics, Inc. , a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing treatments in high unmet need areas involving multi-drug resistant (MDR) bacterial infections and rare diseases, today...
5 Jun 2019
**Update: The US FDA Antimicrobial Drug Advisory Committee voted in favor of the NDA 14 to 4 on June 6th, 2019** The United States Food & Drug Administration (FDA) will host the Antimicrobial Drug Advisory Committee on Thursday, June 6th to discuss the new drug application (NDA) involving new...